James B. McMahon

Discovery of cyanovirin-N, a novel human immunodeficiency virus-inactivating protein that binds viral surface envelope glycoprotein gp120: potential applications to microbicide development

Michael R. Boyd, Kirk R. Gustafson, James B. McMahon et al. · Antimicrobial Agents and Chemotherapy · 1997 · 607 citations · Full text

Viral Replication, Immunology, Escherichia Coli +17

HIV inhibitory natural products. Part 7. The calanolides, a novel HIV-inhibitory class of coumarin derivatives from the tropical rainforest tree, Calophyllum lanigerum

Yoel Kashman, Kirk R. Gustafson, Ray W. Fuller et al. · Journal of Medicinal Chemistry · 1992 · 546 citations

Isolation and Characterization of Griffithsin, a Novel HIV-inactivating Protein, from the Red Alga Griffithsia sp.

Toshiyuki Mori, Barry R. O’Keefe, Raymond C. Sowder et al. · Journal of Biological Chemistry · 2004 · 444 citations · Full text

Initial studies on the cellular pharmacology of 2′,3′-dideoxycytidine, an inhibitor of HTLV-III infectivity

David A. Cooney, Maha Dalal, Hiroaki Mitsuya et al. · Biochemical Pharmacology · 1986 · 322 citations

Medicine, Htlv-iii Infectivity, Antiviral Drug Development +8

Circulins A and B. Novel human immunodeficiency virus (HIV)-inhibitory macrocyclic peptides from the tropical tree Chassalia parvifolia.

Kirk R. Gustafson, Raymond C. Sowder, Louis E. Henderson et al. · Journal of the American Chemical Society · 1994 · 304 citations

Glycobiology, Immunology, Altmetric Attention Score +16